Table 3.
Outcome results and RRI.
| Global population | Cardiothoracic population | |||||
|---|---|---|---|---|---|---|
| RRI < 0.7 | RRI > 0.7 | P | RRI < 0.7 | RRI > 0.7 | P | |
| N | 145 | 60 | 80 | 42 | ||
| Global complications | 27 (18.62%) | 19 (31.67%) | 0.042 | 14 (17.50%) | 15 (35.71%) | 0.042 |
| Suture leak | 2 (1.38%) | 2 (3.33%) | 0.582 | 0 | 0 | |
| Bleeding | 4 (2.76%) | 1 (1.67%) | 1.000 | 3 (3.75%) | 0 | 0.550 |
| ARDS | 1 (0.69%) | 3 (5.00%) | 0.076 | 1 (1.25%) | 3 (7.14%) | 0.117 |
| Pneumonia | 4 (2.76%) | 7 (11.67%) | 0.016 | 1 (1.25%) | 6 (14.29%) | 0.007 |
| Atelectasis | 3 (2.07%) | 3 (5.00%) | 0.361 | 1 (1.25%) | 3 (7.14%) | 0.117 |
| SIRS/Sepsis | 2 (1.38%) | 4 (6.67%) | 0.062 | 2 (2.50%) | 4 (9.52%) | 0.180 |
| Septic shock | 1 (0.69%) | 6 (10.00%) | 0.003 | 0 | 4 (9.52%) | 0.013 |
| ARF | 2 (1.38%) | 8 (13.33%) | 0.001 | 2 (2.50%) | 7 (16.67%) | 0.008 |
| Pulmonary embolism | 0 | 1 (1.67%) | 0.293 | 0 | 1 (2.38%) | 0.344 |
| Acute respiratory failure | 4 (2.76%) | 2 (3.33%) | 1.000 | 1 (1.25%) | 2 (4.76%) | 0.272 |
| Hepatic insufficiency | 1 (0.69%) | 0 | 1.000 | 0 | 0 | |
| Arrhythmia | 8 (5.52%) | 5 (8.33%) | 0.530 | 6 (7.50%) | 4 (9.52%) | 0.735 |
| ICU admission (n) | 56 (38.62%) | 24 (40.00%) | 0.854 | 33 (41.25%) | 18 (42.86%) | 0.864 |
| ICU staying (days) | 1 (1–36) | 4 (1–38) | 0.001 | 3 (1–36) | 5.5 (2–38) | 0.006 |
| Mechanical ventilation (n) | 53 (36.55%) | 19 (31.67%) | 0.505 | 33 (41.25%) | 17 (40.48%) | 0.934 |
| Mechanical ventilation (hours) | 12 (1–240) | 32 (6–300) | 0.004 | 12 (1–240) | 32 (6–300) | 0.001 |
| Length-of-stay (days) | 8 (1–37) | 8 (4–40) | 0.246 | 8 (1–22) | 8 (4–24) | 0.023 |
| Death (n) | 2 (1.38%) | 3 (5.00%) | 0.151 | 1 (1.25%) | 2 (4.76%) | 0.272 |
Complications that did not occur are not reported. Some patients experienced more than 1 adverse event.